Lantern Pharma shareholders elect directors and approve stock option repricing
PositiveFinancial Markets

Lantern Pharma has successfully held its shareholder meeting where directors were elected and stock option repricing was approved. This is significant as it reflects the confidence of shareholders in the company's leadership and strategic direction, potentially enhancing employee motivation and retention through more favorable stock options.
— Curated by the World Pulse Now AI Editorial System